Which share count should HLN investors use for FCA notifiable interest calculations?

Investors should use 8,809,026,622 ordinary shares as the denominator for FCA Disclosure Guidance and Transparency Rules. This represents Haleon’s total ordinary shares with voting rights when determining whether an interest, or change in interest, is notifiable.

Haleon (NYSE: HLN) details share count and voting rights update

Q: What is Haleon (HLN)'s total number of issued shares as of 31 July 2026?

Haleon has 8,820,906,422 ordinary shares of £0.01 each issued as of 31 July 2026. This figure includes all ordinary shares, both those in public hands and those held by the company as treasury shares.

Q: How many Haleon (HLN) shares carry voting rights as of 31 July 2026?

As of 31 July 2026, Haleon has 8,809,026,622 ordinary shares with voting rights . This is the key denominator investors should use when assessing whether their holdings trigger disclosure under the FCA’s guidance and transparency requirements.

Q: How many Haleon (HLN) shares are held as treasury shares?

Haleon holds 11,879,800 ordinary shares as treasury shares. Treasury shares are issued shares held by the company itself and do not carry voting rights, which is why they are excluded from the voting-share denominator.

Q: What type of business is Haleon (HLN) and what products does it offer?

Haleon is a consumer company focused on better everyday health , with products across six categories including Oral Health, VMS, Pain Relief and Respiratory Health. Its brands include Advil, Centrum, Panadol, Sensodyne, Theraflu and others used by over a billion consumers.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Haleon plc reports its share capital and voting structure as at 31 July 2026. The company has 8,820,906,422 ordinary shares of £0.01 each issued, of which 11,879,800 are held as treasury shares. This results in 8,809,026,622 ordinary shares with voting rights.

This voting-share figure is the denominator shareholders and others with notification obligations should use to determine whether they must notify their interest in Haleon under the FCA’s Disclosure Guidance and Transparency Rules.

Key Figures

Total issued shares: 8,820,906,422 ordinary shares Treasury shares: 11,879,800 shares Shares with voting rights: 8,809,026,622 shares +1 more

4 metrics

Total issued shares 8,820,906,422 ordinary shares Total number of shares issued as at 31 July 2026

Treasury shares 11,879,800 shares Ordinary shares held in treasury as at 31 July 2026

Shares with voting rights 8,809,026,622 shares Ordinary shares carrying voting rights, used as FCA disclosure denominator

Nominal value per share £0.01 per ordinary share Par value of each Haleon ordinary share

Key Terms

treasury shares, Disclosure Guidance and Transparency Rules, notifiable interests, Total Voting Rights and Capital

4 terms

treasury shares financial

"of which 11,879,800 are held as treasury shares"

Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.

Disclosure Guidance and Transparency Rules regulatory

"under the FCA's Disclosure Guidance and Transparency Rules"

Disclosure guidance and transparency rules are the standards and regulations that require companies to share clear, timely information about their finances, risks, operations and material events. They matter to investors because consistent, honest reporting is like a car’s dashboard — it reveals the data you need to judge safety and performance and make informed buying or selling decisions. Strong disclosure reduces surprises and helps keep markets fair and efficient.

notifiable interests regulatory

"Notifiable interests in Haleon may be sent to:"

Total Voting Rights and Capital financial

"Haleon plc: Total Voting Rights and Capital"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 08/03/2026 - 06:23 AM Accepted by SEC EDGAR 08/03/2026 - 06:23 AM

FAQ

What is Haleon (HLN)'s total number of issued shares as of 31 July 2026?

Haleon has 8,820,906,422 ordinary shares of £0.01 each issued as of 31 July 2026. This figure includes all ordinary shares, both those in public hands and those held by the company as treasury shares.

How many Haleon (HLN) shares carry voting rights as of 31 July 2026?

As of 31 July 2026, Haleon has 8,809,026,622 ordinary shares with voting rights. This is the key denominator investors should use when assessing whether their holdings trigger disclosure under the FCA’s guidance and transparency requirements.

How many Haleon (HLN) shares are held as treasury shares?

Haleon holds 11,879,800 ordinary shares as treasury shares. Treasury shares are issued shares held by the company itself and do not carry voting rights, which is why they are excluded from the voting-share denominator.

What type of business is Haleon (HLN) and what products does it offer?

Haleon is a consumer company focused on better everyday health, with products across six categories including Oral Health, VMS, Pain Relief and Respiratory Health. Its brands include Advil, Centrum, Panadol, Sensodyne, Theraflu and others used by over a billion consumers.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒

Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	03 August 2026 - “Total Voting Rights and Capital”

99.1

Haleon plc: Total Voting Rights and Capital

03 August 2026: As at 31 July 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,820,906,422 ordinary shares of £0.01 each, of which 11,879,800 are held as treasury shares.

Therefore, the number of ordinary shares with voting rights is 8,809,026,622 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notifiable interests in Haleon may be sent to: company.secretary@haleon.com

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: August 03, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

Source: View Original Filing on SEC EDGAR